nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—ABCB1—Mitomycin—urinary bladder cancer	0.106	0.16	CbGbCtD
Sumatriptan—ABCG2—Fluorouracil—urinary bladder cancer	0.0723	0.11	CbGbCtD
Sumatriptan—ABCG2—Carboplatin—urinary bladder cancer	0.0718	0.109	CbGbCtD
Sumatriptan—ABCG2—Cisplatin—urinary bladder cancer	0.0614	0.0931	CbGbCtD
Sumatriptan—ABCG2—Etoposide—urinary bladder cancer	0.0603	0.0915	CbGbCtD
Sumatriptan—SLCO1A2—Methotrexate—urinary bladder cancer	0.0532	0.0806	CbGbCtD
Sumatriptan—SLCO1B1—Methotrexate—urinary bladder cancer	0.0502	0.0761	CbGbCtD
Sumatriptan—ABCG2—Doxorubicin—urinary bladder cancer	0.0411	0.0624	CbGbCtD
Sumatriptan—ABCG2—Methotrexate—urinary bladder cancer	0.0399	0.0604	CbGbCtD
Sumatriptan—ABCB1—Gemcitabine—urinary bladder cancer	0.0305	0.0462	CbGbCtD
Sumatriptan—ABCB1—Cisplatin—urinary bladder cancer	0.0221	0.0336	CbGbCtD
Sumatriptan—ABCB1—Etoposide—urinary bladder cancer	0.0218	0.033	CbGbCtD
Sumatriptan—ABCB1—Doxorubicin—urinary bladder cancer	0.0148	0.0225	CbGbCtD
Sumatriptan—ABCB1—Methotrexate—urinary bladder cancer	0.0144	0.0218	CbGbCtD
Sumatriptan—Melatonin—MT3—urinary bladder cancer	0.00541	0.688	CrCbGaD
Sumatriptan—Melatonin—MPO—urinary bladder cancer	0.0014	0.178	CrCbGaD
Sumatriptan—Melatonin—ESR1—urinary bladder cancer	0.00105	0.134	CrCbGaD
Sumatriptan—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000147	0.000463	CcSEcCtD
Sumatriptan—Haemoglobin—Methotrexate—urinary bladder cancer	0.000147	0.000462	CcSEcCtD
Sumatriptan—Haemorrhage—Methotrexate—urinary bladder cancer	0.000146	0.00046	CcSEcCtD
Sumatriptan—Sweating—Epirubicin—urinary bladder cancer	0.000146	0.000459	CcSEcCtD
Sumatriptan—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000146	0.000459	CcSEcCtD
Sumatriptan—Asthenia—Gemcitabine—urinary bladder cancer	0.000146	0.000458	CcSEcCtD
Sumatriptan—Haematuria—Epirubicin—urinary bladder cancer	0.000146	0.000457	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000145	0.000454	CcSEcCtD
Sumatriptan—Weight increased—Doxorubicin—urinary bladder cancer	0.000144	0.000453	CcSEcCtD
Sumatriptan—Epistaxis—Epirubicin—urinary bladder cancer	0.000144	0.000452	CcSEcCtD
Sumatriptan—Pruritus—Gemcitabine—urinary bladder cancer	0.000144	0.000452	CcSEcCtD
Sumatriptan—Nausea—Thiotepa—urinary bladder cancer	0.000144	0.000451	CcSEcCtD
Sumatriptan—Weight decreased—Doxorubicin—urinary bladder cancer	0.000143	0.00045	CcSEcCtD
Sumatriptan—Sinusitis—Epirubicin—urinary bladder cancer	0.000143	0.00045	CcSEcCtD
Sumatriptan—Feeling abnormal—Etoposide—urinary bladder cancer	0.000143	0.000449	CcSEcCtD
Sumatriptan—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000143	0.000449	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000142	0.000446	CcSEcCtD
Sumatriptan—Pruritus—Fluorouracil—urinary bladder cancer	0.000142	0.000444	CcSEcCtD
Sumatriptan—Drowsiness—Doxorubicin—urinary bladder cancer	0.000141	0.000443	CcSEcCtD
Sumatriptan—Visual impairment—Methotrexate—urinary bladder cancer	0.000141	0.000443	CcSEcCtD
Sumatriptan—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00014	0.000439	CcSEcCtD
Sumatriptan—Bradycardia—Epirubicin—urinary bladder cancer	0.00014	0.000438	CcSEcCtD
Sumatriptan—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000139	0.000437	CcSEcCtD
Sumatriptan—Urticaria—Etoposide—urinary bladder cancer	0.000138	0.000433	CcSEcCtD
Sumatriptan—Haemoglobin—Epirubicin—urinary bladder cancer	0.000138	0.000432	CcSEcCtD
Sumatriptan—Body temperature increased—Etoposide—urinary bladder cancer	0.000137	0.000431	CcSEcCtD
Sumatriptan—Abdominal pain—Etoposide—urinary bladder cancer	0.000137	0.000431	CcSEcCtD
Sumatriptan—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000137	0.000431	CcSEcCtD
Sumatriptan—Haemorrhage—Epirubicin—urinary bladder cancer	0.000137	0.00043	CcSEcCtD
Sumatriptan—Eye disorder—Methotrexate—urinary bladder cancer	0.000137	0.00043	CcSEcCtD
Sumatriptan—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000137	0.00043	CcSEcCtD
Sumatriptan—Tinnitus—Methotrexate—urinary bladder cancer	0.000137	0.000429	CcSEcCtD
Sumatriptan—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000136	0.000428	CcSEcCtD
Sumatriptan—Asthenia—Cisplatin—urinary bladder cancer	0.000136	0.000427	CcSEcCtD
Sumatriptan—Sweating—Doxorubicin—urinary bladder cancer	0.000135	0.000425	CcSEcCtD
Sumatriptan—Haematuria—Doxorubicin—urinary bladder cancer	0.000135	0.000423	CcSEcCtD
Sumatriptan—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000135	0.000423	CcSEcCtD
Sumatriptan—Epistaxis—Doxorubicin—urinary bladder cancer	0.000133	0.000418	CcSEcCtD
Sumatriptan—Angiopathy—Methotrexate—urinary bladder cancer	0.000133	0.000417	CcSEcCtD
Sumatriptan—Sinusitis—Doxorubicin—urinary bladder cancer	0.000133	0.000416	CcSEcCtD
Sumatriptan—Immune system disorder—Methotrexate—urinary bladder cancer	0.000132	0.000415	CcSEcCtD
Sumatriptan—Dizziness—Fluorouracil—urinary bladder cancer	0.000132	0.000415	CcSEcCtD
Sumatriptan—Visual impairment—Epirubicin—urinary bladder cancer	0.000132	0.000415	CcSEcCtD
Sumatriptan—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000132	0.000414	CcSEcCtD
Sumatriptan—Chills—Methotrexate—urinary bladder cancer	0.000131	0.000413	CcSEcCtD
Sumatriptan—Diarrhoea—Cisplatin—urinary bladder cancer	0.00013	0.000407	CcSEcCtD
Sumatriptan—Vomiting—Gemcitabine—urinary bladder cancer	0.000129	0.000406	CcSEcCtD
Sumatriptan—Bradycardia—Doxorubicin—urinary bladder cancer	0.000129	0.000405	CcSEcCtD
Sumatriptan—Rash—Gemcitabine—urinary bladder cancer	0.000128	0.000403	CcSEcCtD
Sumatriptan—Dermatitis—Gemcitabine—urinary bladder cancer	0.000128	0.000402	CcSEcCtD
Sumatriptan—Eye disorder—Epirubicin—urinary bladder cancer	0.000128	0.000402	CcSEcCtD
Sumatriptan—Hypersensitivity—Etoposide—urinary bladder cancer	0.000128	0.000402	CcSEcCtD
Sumatriptan—Tinnitus—Epirubicin—urinary bladder cancer	0.000128	0.000401	CcSEcCtD
Sumatriptan—Erythema—Methotrexate—urinary bladder cancer	0.000127	0.0004	CcSEcCtD
Sumatriptan—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000127	0.0004	CcSEcCtD
Sumatriptan—Headache—Gemcitabine—urinary bladder cancer	0.000127	0.0004	CcSEcCtD
Sumatriptan—Flushing—Epirubicin—urinary bladder cancer	0.000127	0.000399	CcSEcCtD
Sumatriptan—Vomiting—Fluorouracil—urinary bladder cancer	0.000127	0.000399	CcSEcCtD
Sumatriptan—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000127	0.000398	CcSEcCtD
Sumatriptan—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000126	0.000396	CcSEcCtD
Sumatriptan—Rash—Fluorouracil—urinary bladder cancer	0.000126	0.000396	CcSEcCtD
Sumatriptan—Dermatitis—Fluorouracil—urinary bladder cancer	0.000126	0.000396	CcSEcCtD
Sumatriptan—Headache—Fluorouracil—urinary bladder cancer	0.000125	0.000393	CcSEcCtD
Sumatriptan—Dysgeusia—Methotrexate—urinary bladder cancer	0.000125	0.000392	CcSEcCtD
Sumatriptan—Asthenia—Etoposide—urinary bladder cancer	0.000125	0.000391	CcSEcCtD
Sumatriptan—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000125	0.000391	CcSEcCtD
Sumatriptan—Angiopathy—Epirubicin—urinary bladder cancer	0.000124	0.00039	CcSEcCtD
Sumatriptan—Immune system disorder—Epirubicin—urinary bladder cancer	0.000124	0.000389	CcSEcCtD
Sumatriptan—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000124	0.000388	CcSEcCtD
Sumatriptan—Back pain—Methotrexate—urinary bladder cancer	0.000123	0.000387	CcSEcCtD
Sumatriptan—Chills—Epirubicin—urinary bladder cancer	0.000123	0.000386	CcSEcCtD
Sumatriptan—Pruritus—Etoposide—urinary bladder cancer	0.000123	0.000386	CcSEcCtD
Sumatriptan—Arrhythmia—Epirubicin—urinary bladder cancer	0.000122	0.000384	CcSEcCtD
Sumatriptan—Visual impairment—Doxorubicin—urinary bladder cancer	0.000122	0.000384	CcSEcCtD
Sumatriptan—Nausea—Gemcitabine—urinary bladder cancer	0.000121	0.000379	CcSEcCtD
Sumatriptan—Vomiting—Cisplatin—urinary bladder cancer	0.000121	0.000378	CcSEcCtD
Sumatriptan—Rash—Cisplatin—urinary bladder cancer	0.00012	0.000375	CcSEcCtD
Sumatriptan—Dermatitis—Cisplatin—urinary bladder cancer	0.000119	0.000375	CcSEcCtD
Sumatriptan—Erythema—Epirubicin—urinary bladder cancer	0.000119	0.000375	CcSEcCtD
Sumatriptan—Diarrhoea—Etoposide—urinary bladder cancer	0.000119	0.000373	CcSEcCtD
Sumatriptan—Nausea—Fluorouracil—urinary bladder cancer	0.000119	0.000373	CcSEcCtD
Sumatriptan—Eye disorder—Doxorubicin—urinary bladder cancer	0.000119	0.000372	CcSEcCtD
Sumatriptan—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000118	0.000371	CcSEcCtD
Sumatriptan—Tinnitus—Doxorubicin—urinary bladder cancer	0.000118	0.000371	CcSEcCtD
Sumatriptan—Anaemia—Methotrexate—urinary bladder cancer	0.000118	0.00037	CcSEcCtD
Sumatriptan—Flushing—Doxorubicin—urinary bladder cancer	0.000118	0.000369	CcSEcCtD
Sumatriptan—Flatulence—Epirubicin—urinary bladder cancer	0.000118	0.000369	CcSEcCtD
Sumatriptan—Dysgeusia—Epirubicin—urinary bladder cancer	0.000117	0.000367	CcSEcCtD
Sumatriptan—Back pain—Epirubicin—urinary bladder cancer	0.000115	0.000362	CcSEcCtD
Sumatriptan—Angiopathy—Doxorubicin—urinary bladder cancer	0.000115	0.000361	CcSEcCtD
Sumatriptan—Malaise—Methotrexate—urinary bladder cancer	0.000115	0.000361	CcSEcCtD
Sumatriptan—Dizziness—Etoposide—urinary bladder cancer	0.000115	0.000361	CcSEcCtD
Sumatriptan—Muscle spasms—Epirubicin—urinary bladder cancer	0.000115	0.00036	CcSEcCtD
Sumatriptan—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000115	0.00036	CcSEcCtD
Sumatriptan—Vertigo—Methotrexate—urinary bladder cancer	0.000115	0.00036	CcSEcCtD
Sumatriptan—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000114	0.000359	CcSEcCtD
Sumatriptan—Chills—Doxorubicin—urinary bladder cancer	0.000114	0.000357	CcSEcCtD
Sumatriptan—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000113	0.000356	CcSEcCtD
Sumatriptan—Nausea—Cisplatin—urinary bladder cancer	0.000113	0.000354	CcSEcCtD
Sumatriptan—Cough—Methotrexate—urinary bladder cancer	0.000111	0.000349	CcSEcCtD
Sumatriptan—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000111	0.000347	CcSEcCtD
Sumatriptan—Convulsion—Methotrexate—urinary bladder cancer	0.00011	0.000347	CcSEcCtD
Sumatriptan—Vomiting—Etoposide—urinary bladder cancer	0.00011	0.000347	CcSEcCtD
Sumatriptan—Erythema—Doxorubicin—urinary bladder cancer	0.00011	0.000347	CcSEcCtD
Sumatriptan—Anaemia—Epirubicin—urinary bladder cancer	0.00011	0.000346	CcSEcCtD
Sumatriptan—Agitation—Epirubicin—urinary bladder cancer	0.00011	0.000344	CcSEcCtD
Sumatriptan—Rash—Etoposide—urinary bladder cancer	0.00011	0.000344	CcSEcCtD
Sumatriptan—Dermatitis—Etoposide—urinary bladder cancer	0.000109	0.000343	CcSEcCtD
Sumatriptan—Headache—Etoposide—urinary bladder cancer	0.000109	0.000342	CcSEcCtD
Sumatriptan—Flatulence—Doxorubicin—urinary bladder cancer	0.000109	0.000341	CcSEcCtD
Sumatriptan—Arthralgia—Methotrexate—urinary bladder cancer	0.000109	0.000341	CcSEcCtD
Sumatriptan—Myalgia—Methotrexate—urinary bladder cancer	0.000109	0.000341	CcSEcCtD
Sumatriptan—Chest pain—Methotrexate—urinary bladder cancer	0.000109	0.000341	CcSEcCtD
Sumatriptan—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000108	0.000339	CcSEcCtD
Sumatriptan—Malaise—Epirubicin—urinary bladder cancer	0.000108	0.000338	CcSEcCtD
Sumatriptan—Discomfort—Methotrexate—urinary bladder cancer	0.000107	0.000337	CcSEcCtD
Sumatriptan—Vertigo—Epirubicin—urinary bladder cancer	0.000107	0.000336	CcSEcCtD
Sumatriptan—Syncope—Epirubicin—urinary bladder cancer	0.000107	0.000336	CcSEcCtD
Sumatriptan—Back pain—Doxorubicin—urinary bladder cancer	0.000107	0.000335	CcSEcCtD
Sumatriptan—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000106	0.000333	CcSEcCtD
Sumatriptan—Palpitations—Epirubicin—urinary bladder cancer	0.000105	0.000331	CcSEcCtD
Sumatriptan—Confusional state—Methotrexate—urinary bladder cancer	0.000105	0.000329	CcSEcCtD
Sumatriptan—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000105	0.000329	CcSEcCtD
Sumatriptan—Cough—Epirubicin—urinary bladder cancer	0.000104	0.000327	CcSEcCtD
Sumatriptan—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000104	0.000327	CcSEcCtD
Sumatriptan—Convulsion—Epirubicin—urinary bladder cancer	0.000103	0.000324	CcSEcCtD
Sumatriptan—Infection—Methotrexate—urinary bladder cancer	0.000103	0.000324	CcSEcCtD
Sumatriptan—Nausea—Etoposide—urinary bladder cancer	0.000103	0.000324	CcSEcCtD
Sumatriptan—Hypertension—Epirubicin—urinary bladder cancer	0.000103	0.000323	CcSEcCtD
Sumatriptan—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000102	0.000322	CcSEcCtD
Sumatriptan—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000102	0.00032	CcSEcCtD
Sumatriptan—Anaemia—Doxorubicin—urinary bladder cancer	0.000102	0.00032	CcSEcCtD
Sumatriptan—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000102	0.00032	CcSEcCtD
Sumatriptan—Myalgia—Epirubicin—urinary bladder cancer	0.000102	0.000319	CcSEcCtD
Sumatriptan—Arthralgia—Epirubicin—urinary bladder cancer	0.000102	0.000319	CcSEcCtD
Sumatriptan—Chest pain—Epirubicin—urinary bladder cancer	0.000102	0.000319	CcSEcCtD
Sumatriptan—Agitation—Doxorubicin—urinary bladder cancer	0.000101	0.000318	CcSEcCtD
Sumatriptan—Anxiety—Epirubicin—urinary bladder cancer	0.000101	0.000318	CcSEcCtD
Sumatriptan—Skin disorder—Methotrexate—urinary bladder cancer	0.000101	0.000317	CcSEcCtD
Sumatriptan—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000101	0.000316	CcSEcCtD
Sumatriptan—Discomfort—Epirubicin—urinary bladder cancer	0.0001	0.000315	CcSEcCtD
Sumatriptan—Malaise—Doxorubicin—urinary bladder cancer	9.96e-05	0.000313	CcSEcCtD
Sumatriptan—Dry mouth—Epirubicin—urinary bladder cancer	9.93e-05	0.000312	CcSEcCtD
Sumatriptan—Vertigo—Doxorubicin—urinary bladder cancer	9.92e-05	0.000311	CcSEcCtD
Sumatriptan—Syncope—Doxorubicin—urinary bladder cancer	9.9e-05	0.000311	CcSEcCtD
Sumatriptan—Confusional state—Epirubicin—urinary bladder cancer	9.82e-05	0.000308	CcSEcCtD
Sumatriptan—Palpitations—Doxorubicin—urinary bladder cancer	9.76e-05	0.000306	CcSEcCtD
Sumatriptan—Anaphylactic shock—Epirubicin—urinary bladder cancer	9.74e-05	0.000306	CcSEcCtD
Sumatriptan—Oedema—Epirubicin—urinary bladder cancer	9.74e-05	0.000306	CcSEcCtD
Sumatriptan—Hypotension—Methotrexate—urinary bladder cancer	9.72e-05	0.000305	CcSEcCtD
Sumatriptan—Loss of consciousness—Doxorubicin—urinary bladder cancer	9.7e-05	0.000305	CcSEcCtD
Sumatriptan—Infection—Epirubicin—urinary bladder cancer	9.67e-05	0.000304	CcSEcCtD
Sumatriptan—Cough—Doxorubicin—urinary bladder cancer	9.63e-05	0.000302	CcSEcCtD
Sumatriptan—Shock—Epirubicin—urinary bladder cancer	9.58e-05	0.000301	CcSEcCtD
Sumatriptan—Convulsion—Doxorubicin—urinary bladder cancer	9.56e-05	0.0003	CcSEcCtD
Sumatriptan—Nervous system disorder—Epirubicin—urinary bladder cancer	9.55e-05	0.0003	CcSEcCtD
Sumatriptan—Thrombocytopenia—Epirubicin—urinary bladder cancer	9.53e-05	0.000299	CcSEcCtD
Sumatriptan—Hypertension—Doxorubicin—urinary bladder cancer	9.53e-05	0.000299	CcSEcCtD
Sumatriptan—Tachycardia—Epirubicin—urinary bladder cancer	9.5e-05	0.000298	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	9.48e-05	0.000298	CcSEcCtD
Sumatriptan—Skin disorder—Epirubicin—urinary bladder cancer	9.46e-05	0.000297	CcSEcCtD
Sumatriptan—Hyperhidrosis—Epirubicin—urinary bladder cancer	9.41e-05	0.000295	CcSEcCtD
Sumatriptan—Chest pain—Doxorubicin—urinary bladder cancer	9.4e-05	0.000295	CcSEcCtD
Sumatriptan—Myalgia—Doxorubicin—urinary bladder cancer	9.4e-05	0.000295	CcSEcCtD
Sumatriptan—Arthralgia—Doxorubicin—urinary bladder cancer	9.4e-05	0.000295	CcSEcCtD
Sumatriptan—Anxiety—Doxorubicin—urinary bladder cancer	9.37e-05	0.000294	CcSEcCtD
Sumatriptan—Paraesthesia—Methotrexate—urinary bladder cancer	9.34e-05	0.000293	CcSEcCtD
Sumatriptan—Discomfort—Doxorubicin—urinary bladder cancer	9.29e-05	0.000291	CcSEcCtD
Sumatriptan—Dyspnoea—Methotrexate—urinary bladder cancer	9.28e-05	0.000291	CcSEcCtD
Sumatriptan—Somnolence—Methotrexate—urinary bladder cancer	9.25e-05	0.00029	CcSEcCtD
Sumatriptan—Dry mouth—Doxorubicin—urinary bladder cancer	9.19e-05	0.000289	CcSEcCtD
Sumatriptan—Hypotension—Epirubicin—urinary bladder cancer	9.1e-05	0.000286	CcSEcCtD
Sumatriptan—Confusional state—Doxorubicin—urinary bladder cancer	9.08e-05	0.000285	CcSEcCtD
Sumatriptan—Decreased appetite—Methotrexate—urinary bladder cancer	9.04e-05	0.000284	CcSEcCtD
Sumatriptan—Oedema—Doxorubicin—urinary bladder cancer	9.01e-05	0.000283	CcSEcCtD
Sumatriptan—Anaphylactic shock—Doxorubicin—urinary bladder cancer	9.01e-05	0.000283	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	8.98e-05	0.000282	CcSEcCtD
Sumatriptan—Fatigue—Methotrexate—urinary bladder cancer	8.97e-05	0.000282	CcSEcCtD
Sumatriptan—Infection—Doxorubicin—urinary bladder cancer	8.95e-05	0.000281	CcSEcCtD
Sumatriptan—Pain—Methotrexate—urinary bladder cancer	8.9e-05	0.000279	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	8.87e-05	0.000278	CcSEcCtD
Sumatriptan—Shock—Doxorubicin—urinary bladder cancer	8.86e-05	0.000278	CcSEcCtD
Sumatriptan—Nervous system disorder—Doxorubicin—urinary bladder cancer	8.84e-05	0.000277	CcSEcCtD
Sumatriptan—Thrombocytopenia—Doxorubicin—urinary bladder cancer	8.82e-05	0.000277	CcSEcCtD
Sumatriptan—Tachycardia—Doxorubicin—urinary bladder cancer	8.79e-05	0.000276	CcSEcCtD
Sumatriptan—Skin disorder—Doxorubicin—urinary bladder cancer	8.75e-05	0.000275	CcSEcCtD
Sumatriptan—Paraesthesia—Epirubicin—urinary bladder cancer	8.74e-05	0.000274	CcSEcCtD
Sumatriptan—Hyperhidrosis—Doxorubicin—urinary bladder cancer	8.71e-05	0.000273	CcSEcCtD
Sumatriptan—Dyspnoea—Epirubicin—urinary bladder cancer	8.68e-05	0.000273	CcSEcCtD
Sumatriptan—Somnolence—Epirubicin—urinary bladder cancer	8.66e-05	0.000272	CcSEcCtD
Sumatriptan—Feeling abnormal—Methotrexate—urinary bladder cancer	8.57e-05	0.000269	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Methotrexate—urinary bladder cancer	8.51e-05	0.000267	CcSEcCtD
Sumatriptan—Decreased appetite—Epirubicin—urinary bladder cancer	8.46e-05	0.000266	CcSEcCtD
Sumatriptan—Hypotension—Doxorubicin—urinary bladder cancer	8.42e-05	0.000264	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	8.41e-05	0.000264	CcSEcCtD
Sumatriptan—Fatigue—Epirubicin—urinary bladder cancer	8.39e-05	0.000264	CcSEcCtD
Sumatriptan—Constipation—Epirubicin—urinary bladder cancer	8.33e-05	0.000261	CcSEcCtD
Sumatriptan—Pain—Epirubicin—urinary bladder cancer	8.33e-05	0.000261	CcSEcCtD
Sumatriptan—Urticaria—Methotrexate—urinary bladder cancer	8.27e-05	0.000259	CcSEcCtD
Sumatriptan—Abdominal pain—Methotrexate—urinary bladder cancer	8.23e-05	0.000258	CcSEcCtD
Sumatriptan—Body temperature increased—Methotrexate—urinary bladder cancer	8.23e-05	0.000258	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	8.21e-05	0.000258	CcSEcCtD
Sumatriptan—Paraesthesia—Doxorubicin—urinary bladder cancer	8.09e-05	0.000254	CcSEcCtD
Sumatriptan—Dyspnoea—Doxorubicin—urinary bladder cancer	8.03e-05	0.000252	CcSEcCtD
Sumatriptan—Feeling abnormal—Epirubicin—urinary bladder cancer	8.02e-05	0.000252	CcSEcCtD
Sumatriptan—Somnolence—Doxorubicin—urinary bladder cancer	8.01e-05	0.000251	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Epirubicin—urinary bladder cancer	7.96e-05	0.00025	CcSEcCtD
Sumatriptan—Decreased appetite—Doxorubicin—urinary bladder cancer	7.83e-05	0.000246	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	7.78e-05	0.000244	CcSEcCtD
Sumatriptan—Fatigue—Doxorubicin—urinary bladder cancer	7.77e-05	0.000244	CcSEcCtD
Sumatriptan—Urticaria—Epirubicin—urinary bladder cancer	7.74e-05	0.000243	CcSEcCtD
Sumatriptan—Constipation—Doxorubicin—urinary bladder cancer	7.7e-05	0.000242	CcSEcCtD
Sumatriptan—Pain—Doxorubicin—urinary bladder cancer	7.7e-05	0.000242	CcSEcCtD
Sumatriptan—Abdominal pain—Epirubicin—urinary bladder cancer	7.7e-05	0.000242	CcSEcCtD
Sumatriptan—Body temperature increased—Epirubicin—urinary bladder cancer	7.7e-05	0.000242	CcSEcCtD
Sumatriptan—Hypersensitivity—Methotrexate—urinary bladder cancer	7.67e-05	0.000241	CcSEcCtD
Sumatriptan—Asthenia—Methotrexate—urinary bladder cancer	7.47e-05	0.000234	CcSEcCtD
Sumatriptan—Feeling abnormal—Doxorubicin—urinary bladder cancer	7.42e-05	0.000233	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	7.37e-05	0.000231	CcSEcCtD
Sumatriptan—Pruritus—Methotrexate—urinary bladder cancer	7.36e-05	0.000231	CcSEcCtD
Sumatriptan—Hypersensitivity—Epirubicin—urinary bladder cancer	7.17e-05	0.000225	CcSEcCtD
Sumatriptan—Urticaria—Doxorubicin—urinary bladder cancer	7.16e-05	0.000225	CcSEcCtD
Sumatriptan—Abdominal pain—Doxorubicin—urinary bladder cancer	7.12e-05	0.000224	CcSEcCtD
Sumatriptan—Body temperature increased—Doxorubicin—urinary bladder cancer	7.12e-05	0.000224	CcSEcCtD
Sumatriptan—Diarrhoea—Methotrexate—urinary bladder cancer	7.12e-05	0.000223	CcSEcCtD
Sumatriptan—Asthenia—Epirubicin—urinary bladder cancer	6.99e-05	0.000219	CcSEcCtD
Sumatriptan—Pruritus—Epirubicin—urinary bladder cancer	6.89e-05	0.000216	CcSEcCtD
Sumatriptan—Dizziness—Methotrexate—urinary bladder cancer	6.88e-05	0.000216	CcSEcCtD
Sumatriptan—Diarrhoea—Epirubicin—urinary bladder cancer	6.66e-05	0.000209	CcSEcCtD
Sumatriptan—Hypersensitivity—Doxorubicin—urinary bladder cancer	6.64e-05	0.000208	CcSEcCtD
Sumatriptan—Vomiting—Methotrexate—urinary bladder cancer	6.62e-05	0.000208	CcSEcCtD
Sumatriptan—Rash—Methotrexate—urinary bladder cancer	6.56e-05	0.000206	CcSEcCtD
Sumatriptan—Dermatitis—Methotrexate—urinary bladder cancer	6.55e-05	0.000206	CcSEcCtD
Sumatriptan—Headache—Methotrexate—urinary bladder cancer	6.52e-05	0.000205	CcSEcCtD
Sumatriptan—Asthenia—Doxorubicin—urinary bladder cancer	6.46e-05	0.000203	CcSEcCtD
Sumatriptan—Dizziness—Epirubicin—urinary bladder cancer	6.44e-05	0.000202	CcSEcCtD
Sumatriptan—Pruritus—Doxorubicin—urinary bladder cancer	6.37e-05	0.0002	CcSEcCtD
Sumatriptan—Vomiting—Epirubicin—urinary bladder cancer	6.19e-05	0.000194	CcSEcCtD
Sumatriptan—Nausea—Methotrexate—urinary bladder cancer	6.18e-05	0.000194	CcSEcCtD
Sumatriptan—Diarrhoea—Doxorubicin—urinary bladder cancer	6.16e-05	0.000194	CcSEcCtD
Sumatriptan—Rash—Epirubicin—urinary bladder cancer	6.14e-05	0.000193	CcSEcCtD
Sumatriptan—Dermatitis—Epirubicin—urinary bladder cancer	6.13e-05	0.000193	CcSEcCtD
Sumatriptan—Headache—Epirubicin—urinary bladder cancer	6.1e-05	0.000191	CcSEcCtD
Sumatriptan—Dizziness—Doxorubicin—urinary bladder cancer	5.96e-05	0.000187	CcSEcCtD
Sumatriptan—Nausea—Epirubicin—urinary bladder cancer	5.78e-05	0.000182	CcSEcCtD
Sumatriptan—Vomiting—Doxorubicin—urinary bladder cancer	5.73e-05	0.00018	CcSEcCtD
Sumatriptan—Rash—Doxorubicin—urinary bladder cancer	5.68e-05	0.000178	CcSEcCtD
Sumatriptan—Dermatitis—Doxorubicin—urinary bladder cancer	5.68e-05	0.000178	CcSEcCtD
Sumatriptan—Headache—Doxorubicin—urinary bladder cancer	5.64e-05	0.000177	CcSEcCtD
Sumatriptan—Nausea—Doxorubicin—urinary bladder cancer	5.35e-05	0.000168	CcSEcCtD
Sumatriptan—ABCG2—Metabolism—GSTT1—urinary bladder cancer	1.07e-05	0.000767	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	1.06e-05	0.000759	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL2—urinary bladder cancer	1.05e-05	0.000753	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TERT—urinary bladder cancer	1.05e-05	0.00075	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—JAG1—urinary bladder cancer	1.04e-05	0.000748	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—NQO1—urinary bladder cancer	1.04e-05	0.000746	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PRSS3—urinary bladder cancer	1.03e-05	0.000739	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—TP53—urinary bladder cancer	1.03e-05	0.000739	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—CXCL8—urinary bladder cancer	1.02e-05	0.000733	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—JAG1—urinary bladder cancer	1.02e-05	0.000732	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—HRAS—urinary bladder cancer	1.02e-05	0.000728	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	1.01e-05	0.000723	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1e-05	0.000718	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	9.76e-06	0.0007	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	9.74e-06	0.000698	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—FGFR3—urinary bladder cancer	9.61e-06	0.000689	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	9.6e-06	0.000688	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	9.5e-06	0.000681	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	9.37e-06	0.000671	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ESR1—urinary bladder cancer	9.33e-06	0.000669	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.32e-06	0.000668	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	9.29e-06	0.000666	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.06e-06	0.000649	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	9.03e-06	0.000647	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—CXCL8—urinary bladder cancer	8.98e-06	0.000643	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NQO1—urinary bladder cancer	8.89e-06	0.000637	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—RHOA—urinary bladder cancer	8.82e-06	0.000632	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	8.71e-06	0.000624	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RBX1—urinary bladder cancer	8.7e-06	0.000623	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTP1—urinary bladder cancer	8.68e-06	0.000622	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—RHOA—urinary bladder cancer	8.64e-06	0.000619	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	8.61e-06	0.000617	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	8.61e-06	0.000617	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—S100B—urinary bladder cancer	8.45e-06	0.000606	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—S100B—urinary bladder cancer	8.28e-06	0.000593	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TYMP—urinary bladder cancer	8.25e-06	0.000591	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	8.24e-06	0.000591	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CREBBP—urinary bladder cancer	8.18e-06	0.000586	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TSC1—urinary bladder cancer	8.18e-06	0.000586	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.12e-06	0.000582	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	8.09e-06	0.00058	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	8.09e-06	0.00058	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IGF1—urinary bladder cancer	8.08e-06	0.000579	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—TYMS—urinary bladder cancer	8.07e-06	0.000578	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—EGFR—urinary bladder cancer	8.04e-06	0.000576	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—RHOA—urinary bladder cancer	8.01e-06	0.000574	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	8.01e-06	0.000574	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—NCOR1—urinary bladder cancer	7.97e-06	0.000571	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTM1—urinary bladder cancer	7.97e-06	0.000571	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	7.92e-06	0.000567	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—RHOA—urinary bladder cancer	7.84e-06	0.000562	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JAG1—urinary bladder cancer	7.78e-06	0.000558	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.75e-06	0.000555	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CXCL8—urinary bladder cancer	7.75e-06	0.000555	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GPX1—urinary bladder cancer	7.64e-06	0.000547	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RBX1—urinary bladder cancer	7.64e-06	0.000547	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	7.61e-06	0.000545	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NCOR1—urinary bladder cancer	7.6e-06	0.000545	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—KRAS—urinary bladder cancer	7.59e-06	0.000544	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CXCL8—urinary bladder cancer	7.58e-06	0.000543	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	7.54e-06	0.00054	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ERCC2—urinary bladder cancer	7.5e-06	0.000537	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	7.48e-06	0.000536	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NAT2—urinary bladder cancer	7.46e-06	0.000535	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	7.45e-06	0.000534	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NCOR1—urinary bladder cancer	7.44e-06	0.000533	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTP1—urinary bladder cancer	7.42e-06	0.000531	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—IL2—urinary bladder cancer	7.4e-06	0.00053	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RHOA—urinary bladder cancer	7.4e-06	0.00053	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	7.36e-06	0.000527	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	7.36e-06	0.000527	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—IL2—urinary bladder cancer	7.25e-06	0.000519	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TSC1—urinary bladder cancer	7.18e-06	0.000514	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—MTHFR—urinary bladder cancer	7.05e-06	0.000505	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	7.05e-06	0.000505	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CXCL8—urinary bladder cancer	7.03e-06	0.000504	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	6.92e-06	0.000496	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—TYMS—urinary bladder cancer	6.89e-06	0.000494	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CXCL8—urinary bladder cancer	6.89e-06	0.000493	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ERBB2—urinary bladder cancer	6.85e-06	0.000491	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JAG1—urinary bladder cancer	6.84e-06	0.00049	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NCOR1—urinary bladder cancer	6.81e-06	0.000488	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTM1—urinary bladder cancer	6.81e-06	0.000488	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL2—urinary bladder cancer	6.72e-06	0.000482	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TERT—urinary bladder cancer	6.7e-06	0.00048	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	6.65e-06	0.000476	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL2—urinary bladder cancer	6.58e-06	0.000472	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—RHOA—urinary bladder cancer	6.58e-06	0.000472	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TERT—urinary bladder cancer	6.56e-06	0.00047	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GPX1—urinary bladder cancer	6.53e-06	0.000468	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	6.5e-06	0.000466	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CXCL8—urinary bladder cancer	6.5e-06	0.000466	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—HRAS—urinary bladder cancer	6.46e-06	0.000463	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—RRM2—urinary bladder cancer	6.44e-06	0.000461	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ERCC2—urinary bladder cancer	6.41e-06	0.000459	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—S100B—urinary bladder cancer	6.3e-06	0.000452	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL2—urinary bladder cancer	6.21e-06	0.000445	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	6.17e-06	0.000442	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FGFR3—urinary bladder cancer	6.15e-06	0.00044	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCND1—urinary bladder cancer	6.05e-06	0.000434	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MTHFR—urinary bladder cancer	6.02e-06	0.000432	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FGFR3—urinary bladder cancer	6.02e-06	0.000431	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—RHOA—urinary bladder cancer	5.98e-06	0.000428	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ESR1—urinary bladder cancer	5.97e-06	0.000428	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ENO2—urinary bladder cancer	5.96e-06	0.000427	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HPGDS—urinary bladder cancer	5.96e-06	0.000427	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	5.92e-06	0.000425	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MMP9—urinary bladder cancer	5.88e-06	0.000421	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CDKN1A—urinary bladder cancer	5.86e-06	0.00042	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ESR1—urinary bladder cancer	5.84e-06	0.000419	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PTEN—urinary bladder cancer	5.84e-06	0.000419	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTT1—urinary bladder cancer	5.78e-06	0.000414	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—RHOA—urinary bladder cancer	5.78e-06	0.000414	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCL8—urinary bladder cancer	5.78e-06	0.000414	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PPARG—urinary bladder cancer	5.71e-06	0.00041	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NCOR1—urinary bladder cancer	5.67e-06	0.000406	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EP300—urinary bladder cancer	5.57e-06	0.000399	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—S100B—urinary bladder cancer	5.53e-06	0.000397	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL2—urinary bladder cancer	5.52e-06	0.000396	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CREBBP—urinary bladder cancer	5.49e-06	0.000393	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SRC—urinary bladder cancer	5.42e-06	0.000388	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.42e-06	0.000388	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	5.27e-06	0.000378	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—RHOA—urinary bladder cancer	5.25e-06	0.000376	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCL8—urinary bladder cancer	5.25e-06	0.000376	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CREBBP—urinary bladder cancer	5.23e-06	0.000375	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF1—urinary bladder cancer	5.17e-06	0.00037	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—EGFR—urinary bladder cancer	5.14e-06	0.000368	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CREBBP—urinary bladder cancer	5.12e-06	0.000367	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCL8—urinary bladder cancer	5.07e-06	0.000363	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	5.07e-06	0.000363	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF1—urinary bladder cancer	5.06e-06	0.000362	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EGFR—urinary bladder cancer	5.03e-06	0.000361	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL2—urinary bladder cancer	5.01e-06	0.000359	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TERT—urinary bladder cancer	5e-06	0.000358	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NCOR1—urinary bladder cancer	4.98e-06	0.000357	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PPARG—urinary bladder cancer	4.88e-06	0.00035	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—KRAS—urinary bladder cancer	4.86e-06	0.000348	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MYC—urinary bladder cancer	4.86e-06	0.000348	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	4.85e-06	0.000348	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2—urinary bladder cancer	4.85e-06	0.000347	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NQO1—urinary bladder cancer	4.81e-06	0.000344	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—KRAS—urinary bladder cancer	4.76e-06	0.000341	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EGFR—urinary bladder cancer	4.75e-06	0.00034	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RHOA—urinary bladder cancer	4.73e-06	0.000339	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CREBBP—urinary bladder cancer	4.69e-06	0.000336	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RHOA—urinary bladder cancer	4.63e-06	0.000332	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL8—urinary bladder cancer	4.61e-06	0.00033	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGFR3—urinary bladder cancer	4.58e-06	0.000328	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—urinary bladder cancer	4.5e-06	0.000322	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KRAS—urinary bladder cancer	4.49e-06	0.000321	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ESR1—urinary bladder cancer	4.45e-06	0.000319	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2—urinary bladder cancer	4.4e-06	0.000315	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TERT—urinary bladder cancer	4.39e-06	0.000314	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ERBB2—urinary bladder cancer	4.38e-06	0.000314	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ERBB2—urinary bladder cancer	4.29e-06	0.000307	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	4.23e-06	0.000303	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL8—urinary bladder cancer	4.15e-06	0.000298	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	4.15e-06	0.000297	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HRAS—urinary bladder cancer	4.13e-06	0.000296	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL8—urinary bladder cancer	4.07e-06	0.000292	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HRAS—urinary bladder cancer	4.04e-06	0.00029	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—EP300—urinary bladder cancer	4.04e-06	0.000289	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGFR3—urinary bladder cancer	4.02e-06	0.000288	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—urinary bladder cancer	4.01e-06	0.000287	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—urinary bladder cancer	3.99e-06	0.000286	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2—urinary bladder cancer	3.97e-06	0.000285	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTEN—urinary bladder cancer	3.92e-06	0.000281	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ESR1—urinary bladder cancer	3.91e-06	0.00028	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CREBBP—urinary bladder cancer	3.9e-06	0.00028	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2—urinary bladder cancer	3.89e-06	0.000279	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCND1—urinary bladder cancer	3.87e-06	0.000277	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1—urinary bladder cancer	3.85e-06	0.000276	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—urinary bladder cancer	3.84e-06	0.000275	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EGFR—urinary bladder cancer	3.83e-06	0.000275	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HRAS—urinary bladder cancer	3.81e-06	0.000273	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCND1—urinary bladder cancer	3.79e-06	0.000272	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—urinary bladder cancer	3.76e-06	0.000269	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN1A—urinary bladder cancer	3.74e-06	0.000268	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—EP300—urinary bladder cancer	3.74e-06	0.000268	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTEN—urinary bladder cancer	3.74e-06	0.000268	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TYMS—urinary bladder cancer	3.73e-06	0.000267	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NCOR1—urinary bladder cancer	3.68e-06	0.000264	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTM1—urinary bladder cancer	3.68e-06	0.000264	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—urinary bladder cancer	3.68e-06	0.000264	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN1A—urinary bladder cancer	3.67e-06	0.000263	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTEN—urinary bladder cancer	3.66e-06	0.000262	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—KRAS—urinary bladder cancer	3.62e-06	0.00026	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	3.62e-06	0.000259	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EP300—urinary bladder cancer	3.56e-06	0.000255	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RHOA—urinary bladder cancer	3.53e-06	0.000253	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GPX1—urinary bladder cancer	3.53e-06	0.000253	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EP300—urinary bladder cancer	3.49e-06	0.00025	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SRC—urinary bladder cancer	3.46e-06	0.000248	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ERCC2—urinary bladder cancer	3.46e-06	0.000248	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—EP300—urinary bladder cancer	3.45e-06	0.000247	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CREBBP—urinary bladder cancer	3.43e-06	0.000246	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SRC—urinary bladder cancer	3.39e-06	0.000243	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1—urinary bladder cancer	3.38e-06	0.000242	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EGFR—urinary bladder cancer	3.37e-06	0.000241	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTEN—urinary bladder cancer	3.35e-06	0.00024	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ERBB2—urinary bladder cancer	3.27e-06	0.000234	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MTHFR—urinary bladder cancer	3.26e-06	0.000233	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—EP300—urinary bladder cancer	3.2e-06	0.000229	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—KRAS—urinary bladder cancer	3.18e-06	0.000228	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MYC—urinary bladder cancer	3.1e-06	0.000222	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RHOA—urinary bladder cancer	3.1e-06	0.000222	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL8—urinary bladder cancer	3.1e-06	0.000222	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HRAS—urinary bladder cancer	3.08e-06	0.000221	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MYC—urinary bladder cancer	3.04e-06	0.000218	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGFR—urinary bladder cancer	3.04e-06	0.000218	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGFR—urinary bladder cancer	2.97e-06	0.000213	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2—urinary bladder cancer	2.96e-06	0.000212	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCND1—urinary bladder cancer	2.89e-06	0.000207	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	2.87e-06	0.000206	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KRAS—urinary bladder cancer	2.87e-06	0.000206	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KRAS—urinary bladder cancer	2.81e-06	0.000201	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—urinary bladder cancer	2.8e-06	0.000201	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN1A—urinary bladder cancer	2.79e-06	0.0002	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTEN—urinary bladder cancer	2.79e-06	0.0002	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	2.72e-06	0.000195	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	2.7e-06	0.000194	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EP300—urinary bladder cancer	2.66e-06	0.00019	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARG—urinary bladder cancer	2.64e-06	0.000189	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2—urinary bladder cancer	2.6e-06	0.000186	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SRC—urinary bladder cancer	2.58e-06	0.000185	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—urinary bladder cancer	2.55e-06	0.000183	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CREBBP—urinary bladder cancer	2.54e-06	0.000182	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	2.54e-06	0.000182	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—urinary bladder cancer	2.5e-06	0.000179	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	2.46e-06	0.000176	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	2.45e-06	0.000176	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	2.45e-06	0.000175	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HRAS—urinary bladder cancer	2.44e-06	0.000175	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HRAS—urinary bladder cancer	2.39e-06	0.000171	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EP300—urinary bladder cancer	2.33e-06	0.000167	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MYC—urinary bladder cancer	2.32e-06	0.000166	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SRC—urinary bladder cancer	2.27e-06	0.000163	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGFR—urinary bladder cancer	2.27e-06	0.000162	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KRAS—urinary bladder cancer	2.14e-06	0.000153	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—urinary bladder cancer	2.08e-06	0.000149	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MYC—urinary bladder cancer	2.03e-06	0.000146	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	1.99e-06	0.000143	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—urinary bladder cancer	1.9e-06	0.000136	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	1.88e-06	0.000135	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HRAS—urinary bladder cancer	1.82e-06	0.00013	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.81e-06	0.00013	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—EP300—urinary bladder cancer	1.73e-06	0.000124	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—urinary bladder cancer	1.67e-06	0.00012	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	1.6e-06	0.000114	CbGpPWpGaD
